1. A randomized trial of nearly 1,200 patients tested gabapentin after major cardiac, thoracic, and abdominal surgery.
2. Gabapentin did not reduce hospital stay or improve recovery when added to multimodal analgesia.
3. Early pain and opioid use were slightly lower with gabapentin but differences disappeared after two days.
4. At 4 weeks and 4 months, more patients on gabapentin reported pain, and quality-of-life scores were unchanged.
5. Adverse events were similar between groups. Researchers concluded gabapentin offered no recovery advantage after major surgery.

Source: Anesthesiology